Impact of the Balloon Pulmonary Angioplasty on the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension: From the COMMAND VTE Registry‐2
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.70130 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Tatsunori Noto und 34 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Toho University Medical Center Ohashi Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Angioplasty, Balloon, Pulmonary Embolism, Hypertension, Pulmonary, Arterial Pressure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: COMMAND VTE Registry-2 was partially supported by JSPS KAKENHI (Grant Number JP 21K16022), provided by the Japan Society for the Promotion of Science, located….
Abstract (Originalsprache)
Background
Chronic thromboembolic pulmonary hypertension (CTEPH) is the most serious long‐term complication of acute pulmonary embolism (PE). Balloon pulmonary angioplasty (BPA) has been an effective treatment for improving the prognosis of CTEPH patients.
Aims
This study aimed to evaluate the impact of BPA at each institution on the rate of CTEPH diagnosis based on the observations suggesting that the emergence of effective treatments could draw attention to targeted diseases.
Methods
The COMMAND VTE Registry‐2 is a multicenter, retrospective cohort study of 5197 patients diagnosed with venous thromboembolism (VTE) at 31 medical centers in Japan. The study included 2787 patients with acute PE, who were divided into the BPA‐capable facility group (BPA centers) and the non‐BPA‐capable facility group (non‐BPA centers). We investigated the difference in the rate of CTEPH diagnosis after acute PE between the two groups.
Results
Among patients with acute PE, 723 patients (25.9%) and 2064 patients (74.1%) were diagnosed at BPA centers and non‐BPA centers, respectively. There were 48 patients who were diagnosed with CTEPH, with a median follow‐up period of 747 days. The cumulative 3‐year incidence of CTEPH diagnosis was 5.0% in the BPA centers and 1.4% in the non‐BPA centers (crude hazard ratio [HR]: 3.80; 95% CI: 2.15–6.72; p < 0.001).
Conclusion
The cumulative 3‐year incidence of CTEPH diagnosis after acute PE was significantly greater in BPA centers than in non‐BPA centers, which suggests the importance of appropriate awareness of CTEPH and BPA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Toho University Medical Center Ohashi Hospital, Tokyo, Japan.
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan.
- Department of Cardiovascular Medicine, Kurashiki Central Hospital, Kurashiki, Japan.
- Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.
- Department of Cardiovascular Center, Osaka Red Cross Hospital, Osaka, Japan.
ORCID-Profile: Tatsunori Noto, Yugo Yamashita, Ryuki Chatani, Satoshi Ikeda, Maki Oi, Takuma Takada, Takeshi Kimura
Förderung
- COMMAND VTE Registry-2 was partially supported by JSPS KAKENHI (Grant Number JP 21K16022), provided by the Japan Society for the Promotion of Science, located…
Zitieren
APA
Noto, T., Ikeda, N., Yamashita, Y., Morimoto, T., Chatani, R., Kaneda, K., Nishimoto, Y., Kobayashi, Y., Ikeda, S., Kim, K., Inoko, M., Takase, T., Tsuji, S., Oi, M., Takada, T., Otsui, K., Sakamoto, J., Ogihara, Y., Inoue, T., …, & COMMAND VTE Registry‐2 Investigators (2025). Impact of the Balloon Pulmonary Angioplasty on the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension: From the COMMAND VTE Registry‐2. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70130
Vancouver
Noto T, Ikeda N, Yamashita Y, Morimoto T, Chatani R, Kaneda K, et al. Impact of the Balloon Pulmonary Angioplasty on the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension: From the COMMAND VTE Registry‐2. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70130
BibTeX
@article{Noto2025,
author = {Noto, Tatsunori and Ikeda, Nobutaka and Yamashita, Yugo and Morimoto, Takeshi and Chatani, Ryuki and Kaneda, Kazuhisa and Nishimoto, Yuji and Kobayashi, Yohei and Ikeda, Satoshi and Kim, Kitae and Inoko, Moriaki and Takase, Toru and Tsuji, Shuhei and Oi, Maki and Takada, Takuma and Otsui, Kazunori and Sakamoto, Jiro and Ogihara, Yoshito and Inoue, Takeshi and Usami, Shunsuke and Chen, Po-Min and Togi, Kiyonori and Koitabashi, Norimichi and Hiramori, Seiichi and Doi, Kosuke and Mabuchi, Hiroshi and Tsuyuki, Yoshiaki and Murata, Koichiro and Takabayashi, Kensuke and Nakai, Hisato and Sueta, Daisuke and Shioyama, Wataru and Dohke, Tomohiro and Kimura, Takeshi and COMMAND VTE Registry‐2 Investigators, COMMAND VTE Registry‐2 Investigators},
title = {Impact of the Balloon Pulmonary Angioplasty on the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension: From the COMMAND VTE Registry‐2},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.70130}
}
EUVIMED